151 related articles for article (PubMed ID: 34254153)
61. Feasibility of intrathecal therapeutic injections in spinal muscular atrophy patients via a percutaneous transsacral hiatus route: An initial neuroimaging morphometric study.
Dhawan SS; Trinh A; Massoud TF
Muscle Nerve; 2023 Mar; 67(3):226-230. PubMed ID: 36576208
[TBL] [Abstract][Full Text] [Related]
62. Nusinersen for the treatment of spinal muscular atrophy.
Chiriboga CA
Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620
[TBL] [Abstract][Full Text] [Related]
63. Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study.
Finkel RS; Chiriboga CA; Vajsar J; Day JW; Montes J; De Vivo DC; Bishop KM; Foster R; Liu Y; Ramirez-Schrempp D; Schneider E; Bennett CF; Wong J; Farwell W
Lancet Child Adolesc Health; 2021 Jul; 5(7):491-500. PubMed ID: 34089650
[TBL] [Abstract][Full Text] [Related]
64. Nusinersen treatment of older children and adults with spinal muscular atrophy.
Konersman CG; Ewing E; Yaszay B; Naheedy J; Murphy S; Skalsky A
Neuromuscul Disord; 2021 Mar; 31(3):183-193. PubMed ID: 33608138
[TBL] [Abstract][Full Text] [Related]
65. Cytochemical Characterization of Cerebrospinal Fluid Macrophage Inclusions in Pediatric Patients Receiving Intrathecal Nusinersen (SPINRAZA®) for Spinal Muscular Atrophy.
Schafernak KT; Jacobsen JR; Hernandez D; Kaye RD; Perez SE
Acta Cytol; 2022; 66(1):79-84. PubMed ID: 34515035
[TBL] [Abstract][Full Text] [Related]
66. Successful Combination of Neuraxial and Regional Anesthesia in a Child With Advanced Spinal Muscular Atrophy Type 1 Receiving Maintenance Nusinersen Therapy: A Case Report.
Brown AF; Einhorn LM
A A Pract; 2020 Apr; 14(6):e01206. PubMed ID: 32784322
[TBL] [Abstract][Full Text] [Related]
67. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.
Finkel RS; Chiriboga CA; Vajsar J; Day JW; Montes J; De Vivo DC; Yamashita M; Rigo F; Hung G; Schneider E; Norris DA; Xia S; Bennett CF; Bishop KM
Lancet; 2016 Dec; 388(10063):3017-3026. PubMed ID: 27939059
[TBL] [Abstract][Full Text] [Related]
68. Intrathecal nusinersen treatment after ventriculo-peritoneal shunt placement: A case report focusing on the neurofilament light chain in cerebrospinal fluid.
Tozawa T; Kasai T; Tatebe H; Shiomi K; Nishio H; Tokuda T; Chiyonobu T
Brain Dev; 2020 Mar; 42(3):311-314. PubMed ID: 31889567
[TBL] [Abstract][Full Text] [Related]
69. Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen.
Jochmann E; Steinbach R; Jochmann T; Chung HY; Rödiger A; Neumann R; Mayer TE; Kirchhof K; Loudovici-Krug D; Smolenski UC; Witte OW; Grosskreutz J
Ther Adv Neurol Disord; 2020; 13():1756286420907803. PubMed ID: 32180828
[TBL] [Abstract][Full Text] [Related]
70. Lumbar laminotomy for the intrathecal administration of nusinersen for spinal muscular atrophy: technical note and outcomes.
Ko D; Blatt D; Karam C; Gupta K; Raslan AM
J Neurosurg Spine; 2019 Apr; 31(2):217-221. PubMed ID: 31003222
[TBL] [Abstract][Full Text] [Related]
71. Scoliosis Orthopedic Surgery Combined With Nusinersen Intrathecal Injection Significantly Improved the Outcome of Spinal Muscular Atrophy Patient: A Case Report.
Xu B; Wei C; Hu X; Li W; Huang Z; Que C; Qiu J; Li C; Xiong H
Front Neurol; 2022; 13():869230. PubMed ID: 35547367
[TBL] [Abstract][Full Text] [Related]
72. Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy.
Stolte B; Totzeck A; Kizina K; Bolz S; Pietruck L; Mönninghoff C; Guberina N; Oldenburg D; Forsting M; Kleinschnitz C; Hagenacker T
Ther Adv Neurol Disord; 2018; 11():1756286418803246. PubMed ID: 30305849
[TBL] [Abstract][Full Text] [Related]
73. Efficacy of nusinersen in type 1, 2 and 3 spinal muscular atrophy: Real world data from Hungarian patients.
Szabó L; Gergely A; Jakus R; Fogarasi A; Grosz Z; Molnár MJ; Andor I; Schulcz O; Goschler Á; Medveczky E; Czövek D; Herczegfalvi Á
Eur J Paediatr Neurol; 2020 Jul; 27():37-42. PubMed ID: 32456992
[TBL] [Abstract][Full Text] [Related]
74. Nusinersen does not improve lung function in a cohort of children with spinal muscular atrophy - A single-center retrospective study.
Heitschmidt L; Pichlmaier L; Eckerland M; Steindor M; Olivier M; Fuge I; Kölbel H; Hirtz R; Stehling F
Eur J Paediatr Neurol; 2021 Mar; 31():88-91. PubMed ID: 33711791
[TBL] [Abstract][Full Text] [Related]
75. Image-guided intrathecal baclofen pump catheter implantation: a technical note and case series.
Robinson S; Robertson FC; Dasenbrock HH; O'Brien CP; Berde C; Padua H
J Neurosurg Spine; 2017 May; 26(5):621-627. PubMed ID: 28156208
[TBL] [Abstract][Full Text] [Related]
76. Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study.
Weiß C; Ziegler A; Becker LL; Johannsen J; Brennenstuhl H; Schreiber G; Flotats-Bastardas M; Stoltenburg C; Hartmann H; Illsinger S; Denecke J; Pechmann A; Müller-Felber W; Vill K; Blaschek A; Smitka M; van der Stam L; Weiss K; Winter B; Goldhahn K; Plecko B; Horber V; Bernert G; Husain RA; Rauscher C; Trollmann R; Garbade SF; Hahn A; von der Hagen M; Kaindl AM
Lancet Child Adolesc Health; 2022 Jan; 6(1):17-27. PubMed ID: 34756190
[TBL] [Abstract][Full Text] [Related]
77. Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care.
Sansone VA; Albamonte E; Salmin F; Casiraghi J; Pirola A; Bettinelli M; Rao F; Mancini L; Tovaglieri N; Fedeli F; Stoia P; Heinen M; Cozzi V; Carraro E; Lunetta C; Di Bari A; Mercuri E;
Neurol Sci; 2019 Feb; 40(2):327-332. PubMed ID: 30430317
[TBL] [Abstract][Full Text] [Related]
78. A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript "single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1" written by pechmann and colleagues".
Sansone VA; Pane M; Messina S; Bruno C; D'Amico A; Albamonte E; Catteruccia M; Sframeli M; Pedemonte M; Vita G; Bertini E; Mercuri E;
Eur J Paediatr Neurol; 2018 Jul; 22(4):729-731. PubMed ID: 29673809
[No Abstract] [Full Text] [Related]
79. A retrospective comparison of intrathecal morphine and epidural hydromorphone for analgesia following posterior spinal fusion in adolescents with idiopathic scoliosis.
Hong RA; Gibbons KM; Li GY; Holman A; Voepel-Lewis T
Paediatr Anaesth; 2017 Jan; 27(1):91-97. PubMed ID: 27878902
[TBL] [Abstract][Full Text] [Related]
80. Transforaminal lumbar puncture for intrathecal access: Case series with literature review and comparison to other techniques.
Velayudhan V; Patel S; Danziger A; Grigorian A; Waite S; Efendizade A
J Clin Neurosci; 2020 Feb; 72():114-118. PubMed ID: 31980274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
